Medicover AB (publ)
MCVEF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,091,800 | $1,746,400 | $1,510,200 | $1,377,400 |
| % Growth | 19.8% | 15.6% | 9.6% | – |
| Cost of Goods Sold | $1,643,500 | $1,387,000 | $1,174,600 | $982,400 |
| Gross Profit | $448,300 | $359,400 | $335,600 | $395,000 |
| % Margin | 21.4% | 20.6% | 22.2% | 28.7% |
| R&D Expenses | $7,000 | $0 | $4,300 | $2,700 |
| G&A Expenses | $57,800 | $219,200 | $40,500 | $34,500 |
| SG&A Expenses | $93,700 | $297,100 | $64,200 | $54,700 |
| Sales & Mktg Exp. | $35,900 | $77,900 | $23,700 | $20,200 |
| Other Operating Expenses | $277,300 | $900 | $0 | $300 |
| Operating Expenses | $378,000 | $298,000 | $278,600 | $235,600 |
| Operating Income | $70,300 | $61,400 | $55,500 | $159,400 |
| % Margin | 3.4% | 3.5% | 3.7% | 11.6% |
| Other Income/Exp. Net | -$50,200 | -$37,800 | -$36,000 | -$15,600 |
| Pre-Tax Income | $20,100 | $23,600 | $19,500 | $143,800 |
| Tax Expense | $5,500 | $5,200 | $5,800 | $37,200 |
| Net Income | $16,700 | $17,600 | $11,800 | $101,800 |
| % Margin | 0.8% | 1% | 0.8% | 7.4% |
| EPS | 0.11 | 0.12 | 0.075 | 0.67 |
| % Growth | -8.3% | 59.4% | -88.8% | – |
| EPS Diluted | 0.11 | 0.12 | 0.075 | 0.67 |
| Weighted Avg Shares Out | 150,139 | 149,361 | 148,712 | 148,351 |
| Weighted Avg Shares Out Dil | 150,197 | 149,652 | 148,954 | 148,351 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,941 | $4,400 | $2,742 | $1,000 |
| Interest Expense | $60,522 | $51,400 | $35,042 | $20,100 |
| Depreciation & Amortization | $98,000 | $182,400 | $161,900 | $111,000 |
| EBITDA | $171,200 | $257,400 | $215,900 | $274,900 |
| % Margin | 8.2% | 14.7% | 14.3% | 20% |